OPUS GENETICS INC. - COMMON STOCK
1.1800
01-11月-24 15:59:56
15 分の遅延
株式
-0.0200
-1.67%
本日の幅
1.1600 - 1.2185
ISIN
N/A
ソース
NASDAQ
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 11 2023 16:38:14 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 11 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
02 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 11 2023 16:52:46 提供 Nasdaq GlobeNewswire
-
01 11 2023 08:05:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at AAO 2023 and Eyecelerator Retina Showcase
26 10 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
06 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
27 9 2023 08:00:12 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Participate in Three Upcoming Investment Bank Conferences
11 9 2023 09:41:55 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
07 9 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposium
28 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
11 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
08 8 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
26 7 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 7 2023 17:19:14 提供 Nasdaq GlobeNewswire
-
27 6 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
21 6 2023 08:00:00 提供 Nasdaq GlobeNewswire